The earnings season is off to a good start. So far, more than 78% of the S&P 500 companies that have reported have topped analyst expectations, according to FactSet.
Better-than-expected retail sales data also lifted sentiment on Wall Street.
Retail sales in the U.S. rose by 1.6% last month, the strongest gain since September 2017.
“The retail sales figures add to the slightly more positive tone of the recent data and provide some comfort that the economy isn’t falling off a cliff,” wrote Andrew Hunter, senior U.S. economist at Capital Economics, in a note. “But they don’t change our view that the fading of the fiscal boost and the lagged impact of the Fed’s monetary tightening will push GDP growth below its 2% potential pace over the coming quarters.”
However, Wall Street headed for a muted weekly performance amid a sharp decline in the health-care sector. The Dow and Nasdaq were up 0.6% and 0.2% for the week, respectively, while the S&P 500 was down marginally.
The health-care sector is down more than 4% this week as investors worry over proposals pushed by Democratic lawmakers. UnitedHealth CEO David Wichmann told analysts in a conference call earlier this week that propositions like “Medicare for All” would “jeopardize the relationship people have with their doctors, destabilize the nation’s health system and limit the ability of clinicians to practice medicine at their best.”
Shares of Regeneron Pharmaceuticals and HCA Healthcare led the decline in the sector this week, falling more 15.2% and 11.8%, respectively. The decline within the sector has been broad based, however. Nearly 80% of health-care stocks were below their 50-day moving averages. By comparison, 90% of tech stocks were above their 50-day averages.
Source: CNBC
Read more:
25 Canada Square, Level 33, office 50, Canary Wharf London, E14 5LQ +44 20 3608 6256
World Financial Markets - 0700 17 600 Varchev Exchange - 0700 115 44
Varchev Finance Ltd is registered in the FCA (FINANCIAL CONDUCT AUTHORITY) with a passport in the United Kingdom: FCA, United Kingdom - registration number: 494 045, which allows provision of financial services in the United Kingdom.
Varchev Finance Ltd strictly comply with the statutes of the European directive MiFID (Markets in Financial Instruments). targeting increased efficiency, transparency and uniformity of financial instruments.
Varchev Finance Ltd is authorized and regulated by the Financial Supervision Commission - Sofia, Bulgaria: License number RG-03-02-05 / 15.03.2006
The information on this site is not intended for distribution or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.
Disclaimer:
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63,41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.